UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 7, 2022 4:30 P.M.
Form:
S-3
CIK:
0001692830
Company Name:
Satsuma Pharmaceuticals, Inc.
File Number:
333-268035